Background
Caloric restriction, or reducing energy intake without causing malnutrition, has long been studied as a strategy to improve metabolic health and potentially slow biological aging. In many experimental models, and in some human studies, sustained calorie reduction improves insulin sensitivity, lowers circulating insulin levels, and favorably affects hormonal pathways linked to growth, nutrient sensing, and aging.
One of the key pathways involved is the insulin–IGF-1 axis. Insulin and insulin-like growth factor 1 (IGF-1) are central hormones in metabolism. They help regulate how the body uses glucose, stores fat, and responds to nutrient availability. When this pathway is overactive, it is often associated with insulin resistance, increased type 2 diabetes risk, and possibly accelerated aging processes. Because of this, researchers have been interested in whether weight loss through caloric restriction can improve this pathway and whether those benefits persist over time.
However, weight loss is not always permanent. Many people who initially lose weight later regain some or all of it. The long-term health consequences of that regain, especially after a structured calorie-reduction program, are not fully understood. This post hoc analysis from the CALERIE-2 trial examined whether sustained weight loss and weight regain after one year of caloric restriction lead to different metabolic and hormonal outcomes over two years.
What CALERIE-2 Studied
The Comprehensive Assessment of Long-term Effects of Reducing Intake of Energy 2, or CALERIE-2, was a 2-year randomized controlled trial involving healthy adults who were not obese. A total of 220 participants were randomly assigned to either a 25% calorie-restriction group or a control group that continued their usual diet.
The intervention was designed to produce weight loss during the first 6 to 12 months, followed by a maintenance phase during the second year. The trial allowed researchers to assess not only the direct effects of calorie reduction, but also what happened when participants maintained weight loss, kept losing weight, or regained weight later on.
In this analysis, researchers did not focus only on the original randomization group. Instead, they grouped participants according to their actual weight trajectory over the 2 years. This is important because some people in the calorie-restriction arm regained weight, while some in the control arm lost weight or stayed stable. To reduce bias from these natural differences, the investigators used propensity score weighting, a statistical technique that helps balance the groups more fairly when comparing outcomes.
Available cardiometabolic and hormonal data from 190 participants were included, along with a biomarker-based estimate of biological age. Biological age is an estimate of how “old” the body appears at a molecular or physiological level, which may differ from chronological age.
How Participants Were Grouped
Between months 12 and 24, the participants fell into three broad patterns:
1. Maintenance group: 112 participants stayed roughly stable in weight.
2. Continued weight-loss group: 58 participants kept losing weight.
3. Weight-regain group: 20 participants regained more than 5% of their baseline weight.
At 12 months, both the calorie-restriction and control groups had lost a similar amount of weight overall, about 5.0 to 5.8 kg. The weight-regain group had started with the largest reductions in calorie intake, suggesting that people who achieved the greatest early restriction were not necessarily the ones who maintained the benefit over time.
Main Findings
The most important finding was that weight regain appeared to undo some of the metabolic benefits gained during caloric restriction.
Specifically, the group that regained weight showed reversal of improvements in insulin area under the curve, a measure that reflects the body’s insulin response over time after a glucose challenge. A higher insulin area under the curve often suggests that the body needs to produce more insulin to manage blood sugar, which is a sign of worsening insulin sensitivity or compensatory hyperinsulinemia.
The weight-regain group also showed reversal in the ratio of IGF-1 to insulin-like growth factor-binding protein 1 (IGFBP-1). This ratio is relevant because IGFBP-1 helps regulate the amount of active IGF-1 available in the bloodstream. Changes in this balance can influence nutrient sensing, growth signaling, and metabolic risk.
By contrast, participants who maintained their weight loss or continued to lose weight tended to preserve the metabolic benefits associated with calorie restriction. These sustained weight-loss groups showed more favorable hormonal profiles and greater reductions in estimated biological age.
Why the Insulin–IGF-1 Pathway Matters
The insulin–IGF-1 pathway sits at the intersection of metabolism, growth, and aging biology. When this pathway functions in a more restrained way, the body often becomes more efficient at handling nutrients, and insulin sensitivity may improve. In many longevity studies, lower activity in nutrient-sensing pathways is linked to better metabolic health and, in some contexts, longer lifespan.
In practical terms, improved insulin sensitivity means the body can use insulin more effectively. That matters because insulin resistance is a major driver of prediabetes and type 2 diabetes. If the body becomes resistant, the pancreas must release more insulin to keep blood sugar normal. Over time, this compensation can fail, leading to rising glucose levels and diabetes.
The CALERIE-2 findings suggest that weight loss alone is not enough if it is followed by meaningful regain. The benefits seen during calorie restriction may be fragile and can diminish when body weight returns upward.
Biological Age and Aging-Related Implications
An especially notable aspect of this analysis was the biomarker-based estimate of biological age. Participants who sustained weight loss had greater reductions in biological age, suggesting a possible slowing of aging-related processes at the molecular level.
This does not mean calorie restriction literally makes someone younger. Rather, it suggests that some measurable biological markers associated with aging may improve when healthy weight loss is maintained. The reversal seen with weight regain reinforces the idea that the body’s metabolic state, not just the number on the scale at one point in time, influences aging-related risk.
This is clinically important because type 2 diabetes and accelerated cardiometabolic aging often travel together. Interventions that improve insulin sensitivity may therefore offer benefits that extend beyond glucose control alone.
Clinical Meaning for Patients and Clinicians
This study offers a clear message: sustained, moderate weight loss is more beneficial than short-term weight loss followed by regain.
For patients, the findings support the idea that the long-term goal is not just to lose weight quickly, but to develop a pattern that can be maintained. That may include realistic calorie reduction, regular physical activity, adequate protein intake, sleep optimization, stress management, and behavioral support. These measures can help prevent the common cycle of loss and regain.
For clinicians, the study highlights the value of monitoring more than body weight alone. A person who loses weight and later regains it may lose some of the metabolic gains that were expected from the initial intervention. Tracking fasting glucose, insulin-related markers when appropriate, lipids, waist circumference, and overall lifestyle adherence may provide a more complete picture.
It is also worth noting that caloric restriction is not the same as unsupervised dieting. In research settings, it is carefully structured to avoid undernutrition. In real-world practice, overly aggressive dieting may be difficult to maintain and could increase the risk of rebound eating or muscle loss. A more moderate, sustainable approach is often more effective in the long term.
What This Study Does and Does Not Prove
This was a post hoc analysis, which means the researchers examined a question after the trial had already been completed. That makes the findings valuable and hypothesis-generating, but not as definitive as a study designed from the outset to compare weight-loss maintenance versus regain.
There are also some limitations. The number of participants who regained more than 5% of baseline weight was relatively small, which means estimates for that group are less precise. In addition, the participants were generally healthy adults and not people with established diabetes, so the results may not apply in exactly the same way to patients with obesity, diabetes, or other chronic illnesses.
Even so, the pattern is biologically plausible and consistent with broader evidence showing that weight regain can blunt the benefits of lifestyle interventions.
Practical Takeaways
Several useful lessons can be drawn from this study:
1. Weight loss benefits depend on maintenance. Temporary improvement may not be enough if weight is later regained.
2. The insulin–IGF-1 pathway is sensitive to body-weight changes. This pathway appears to improve with sustained restriction but can worsen again after regain.
3. Biological aging markers may also respond to long-term weight patterns. Sustained loss was linked to more favorable aging-related biomarker changes.
4. Sustainable strategies matter more than aggressive short-term dieting. Moderate, maintainable changes are more likely to protect long-term metabolic health.
5. Preventing weight regain should be a core part of treatment. Follow-up support is essential after an initial weight-loss success.
Conclusion
The CALERIE-2 post hoc analysis adds important nuance to the science of caloric restriction and weight management. It shows that substantial weight loss can improve insulin sensitivity and hormonal markers linked to the insulin–IGF-1 nutrient-sensing pathway, but those gains may fade or reverse if weight is regained.
In contrast, sustaining a moderate weight loss appears to preserve metabolic benefits and may even be associated with a healthier biological aging profile. For people concerned about type 2 diabetes risk and long-term metabolic health, the message is not simply to lose weight, but to keep it off in a safe, realistic, and sustainable way.
As with many aspects of preventive medicine, consistency matters. The body responds not only to how much weight is lost, but also to whether that improvement can be maintained over time.
